30.80 -0.20 (-0.65%)

31.49% Fall from 52W High

3,428 BSE Volume

BSE 07 Apr, 2025 3:31 PM (IST)



Board Meetings - Concord Drugs Ltd.

The latest board meeting for Concord Drugs Ltd. took place on 17 Mar 2025, for the purpose of Preferential Issue of shares & Others

Ex-date Purpose Notes
17 Mar 2025 Preferential Issue of shares & Others Inter-alia, to consider 1. Increase in Authorized share Capital. 2. Other business matters. (Revised)
11 Jan 2025 Quarterly Results -
13 Nov 2024 Quarterly Results -
09 Aug 2024 Quarterly Results -
30 May 2024 Audited Results (Revised)
13 Feb 2024 Quarterly Results -
14 Nov 2023 Quarterly Results -
14 Aug 2023 Quarterly Results -
30 May 2023 Audited Results -
14 Feb 2023 Quarterly Results -
14 Nov 2022 Quarterly Results -
06 Aug 2022 Quarterly Results -
30 May 2022 Audited Results -
14 Feb 2022 Quarterly Results -
18 Oct 2021 Quarterly Results -
13 Aug 2021 Quarterly Results -
28 Jun 2021 Audited Results -
13 Feb 2021 Quarterly Results -
13 Nov 2020 Quarterly Results -
14 Sep 2020 Quarterly Results -
27 Jun 2020 Audited Results -
13 Feb 2020 Quarterly Results -
14 Nov 2019 Quarterly Results -
14 Aug 2019 Quarterly Results (Revised)
13 Aug 2019 Quarterly Results -
30 May 2019 Audited Results -
14 Feb 2019 Quarterly Results (Revised)
13 Feb 2019 Quarterly Results -
14 Nov 2018 Quarterly Results -
14 Aug 2018 Unaudited Financial Results -
30 May 2018 Audited Results -
14 Feb 2018 Quarterly Results (Revised)
13 Feb 2018 Quarterly Results -
14 Dec 2017 Quarterly Results (Revised)
15 Nov 2017 Others -
02 Sep 2017 Quarterly Results -
28 Aug 2017 Quarterly Results -
30 May 2017 Audited Results -
14 Feb 2017 Quarterly Results -
14 Nov 2016 Quarterly Results -
13 Aug 2016 Quarterly Results -
07 Jul 2016 Restructuring of the Board -
13 Feb 2016 Quarterly Results -
14 Nov 2015 Quarterly Results -
14 Aug 2015 Audited Results -
30 May 2015 Audited Results -
30 Mar 2015 Others 1. Appointment of Ms. P. Chandra Kala as Woman Director. 2.Redesignation of Mr. Koni Reddy as Director & CFO.